Coronis Fusion 4MP (MDCC-4630); Coronis Fusion 6MP (MDCC-6630)
Barco NV · Decision date Oct 2, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SE) decision for K262412 on 2026-10-02, covering the Coronis Fusion 4MP (MDCC-4630) and Coronis Fusion 6MP (MDCC-6630) under applicant Barco NV. The submission was received 07/15/2026 and reviewed in the Radiology panel, with product code PGY listed for the diagnostic radiology display category. SE denotes 510(k) clearance rather than PMA approval.
The record identifies the devices by model number but does not describe the specific component, software version or change that the submission addressed, and no summary statement is included in the available data. The decision therefore establishes clearance status only; comparative performance against the predicate, display specifications and any labeled indications remain in the underlying FDA documents, which were not reviewed here.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Radiology
- Decision date
- Oct 2, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262412
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Barco NV
- Product code
- PGY
- Decision code
- SESE
- Decision date
- Oct 2, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Display, Diagnostic Radiology.
FDA decision timeline
K262412 received
Application receipt date recorded by FDA.
K262412 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code PGY
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Medical Monitor (32MD08WC)K262985 | Lg Electronics.Inc | 510(k) clearance | Oct 2, 2026 | FDA |
RadiForce MX247WK262783 | Eizo Corporation | 510(k) clearance | Sep 1, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Barco NV
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Kortrijk
Sources and methodology
- Original FDA record: K262412
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
